Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Other Non-Current Liabilities (2020 - 2026)

Treace Medical Concepts filings provide 6 years of Other Non-Current Liabilities readings, the most recent being $3.0 million for Q4 2025.

  • On a quarterly basis, Other Non-Current Liabilities rose 3043.3% to $3.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $3.0 million, a 3043.3% increase, with the full-year FY2025 number at $3.0 million, up 3043.3% from a year prior.
  • Other Non-Current Liabilities hit $3.0 million in Q4 2025 for Treace Medical Concepts, up from $37000.0 in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $3.0 million in Q4 2025 to a low of $25000.0 in Q1 2023.
  • Median Other Non-Current Liabilities over the past 5 years was $97000.0 (2024), compared with a mean of $279470.6.
  • The widest YoY moves for Other Non-Current Liabilities: up 3043.3% in 2025, down 76.58% in 2025.
  • Treace Medical Concepts' Other Non-Current Liabilities stood at $173000.0 in 2021, then tumbled by 52.02% to $83000.0 in 2022, then plummeted by 55.42% to $37000.0 in 2023, then surged by 162.16% to $97000.0 in 2024, then skyrocketed by 3043.3% to $3.0 million in 2025.
  • The last three reported values for Other Non-Current Liabilities were $3.0 million (Q4 2025), $37000.0 (Q3 2025), and $154000.0 (Q2 2025) per Business Quant data.